melatonin | Evidence search

Click export CSV or RIS to download the entire page or use the checkboxes to select a subset of records to download

MELATONIN | Drug

Source: British National Formulary - BNF - 14 March 2019

Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for MELATONIN.

More: Prescribing and Technical Information
Melatonin for the management of sleep disorders in children and adolescents

Source: Canadian Paediatric Society - 31 May 2012 - Publisher: Canadian Paediatric Society

Problems of sleep initiation and maintenance occur in 15% to 25% of children and adolescents. Studies of the benefits of melatonin for sleep disorders have been published for healthy populations, ...

Read Summary

- More: Guidance
melatonin (Slenyto®)

Source: All Wales Medicines Strategy Group - AWMSG - 28 March 2019

-- All Wales Medicines Strategy Group (AWMSG) - melatonin (Slenyto)

More: Prescribing and Technical Information

- More: Guidance
Melatonin | Interactions

Source: British National Formulary - BNF - 14 March 2019

A list of drugs that interact with Melatonin.

More: Prescribing and Technical Information
Bulletin 108 Melatonin (SPOT-List)

Source: PrescQIPP - 16 August 2016 - Publisher: PrescQIPP

The Melatonin SPOT-List support document reviews the place in therapy for melatonin and recommends reviewing patients regularly to assess for continued need. A shared care template document is...

Read Summary

- More: Prescribing and Technical Information
MELATONIN | Drug

Source: British National Formulary for Children - BNFc - 14 March 2019

Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for MELATONIN.

More: Prescribing and Technical Information
Melatonin | Interactions

Source: British National Formulary for Children - BNFc - 14 March 2019

A list of drugs that interact with Melatonin.

More: Prescribing and Technical Information
Melatonin 10mg capsules: Company-led recall

Source: Medicines and Healthcare products Regulatory Agency - MHRA - Source: GOV UK - 17 July 2018 - Publisher: Medicines and Healthcare products Regulatory Agency

IPS Specials are recalling specific batches of Melatonin 10 mg capsules because they have been assigned an incorrect extended expiry date.

Read Summary

- More: Safety Alerts
Melatonin Teva XL 2 mg prolonged-release tablets and Celton XL 2 mg prolonged-release tablets (melatonin) PL 00289/2202-2203 UK/H/6708-6709/001/DC [PDF]

Source: Medicines and Healthcare products Regulatory Agency - MHRA - 06 November 2018 - Publisher: MHRA;Gov UK

This is just the first MHRA Public Assessment Report from your search. See all

Decentralised Procedure Melatonin Teva XL 2 mg prolonged-release tablets Celton XL 2 mg prolonged-release tablets...

More: Prescribing and Technical Information
Melatonin for sleep problems in children with neurodevelopmental disorders

15 October 2015 - Publisher: Drug and Therapeutics Bulletin

This reviews off-label and unlicensed use of melatonin in children with attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder or related neurodevelopmental disorders. See also...

Read Summary

- More: Evidence Summaries

Filter results by

Results for melatonin

1 - 10 of 767 sorted by relevance / date

MELATONIN | Drug

Melatonin for the management of sleep disorders in children and adolescents

melatonin (Slenyto®)

Melatonin | Interactions

Bulletin 108 Melatonin (SPOT-List)

MELATONIN | Drug

Melatonin | Interactions

Melatonin 10mg capsules: Company-led recall

Melatonin Teva XL 2 mg prolonged-release tablets and Celton XL 2 mg prolonged-release tablets (melatonin) PL 00289/2202-2203 UK/H/6708-6709/001/DC [PDF]

Melatonin for sleep problems in children with neurodevelopmental disorders